HCD-510

N/A

Report date: 2025/03/17 14:58:04

Base Information

Drug NameHCD-510
Drug Alias NameHCD-510HCD510
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMicro Life Technology Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMicro Life Technology Group Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A